GeBBS Healthcare Solutions Announces Sale to EQT Private Capital Asia

Cooley advised GeBBS Healthcare Solutions, a global provider of healthcare outsourcing solutions, and ChrysCapital, a top India-focused private equity firm, on the agreement for BPEA Private Equity Fund VIII (EQT Private Capital Asia) to acquire a controlling beneficial interest in GeBBS from ChrysCapital.  GeBBS Healthcare Solutions Announces Sale to EQT Private […]

Confluent Acquires WarpStream

Cooley advised Confluent (Nasdaq: CFLT), a data-streaming platform pioneering a fundamentally new category of data infrastructure that sets data in motion, on its acquisition of WarpStream, an Apache Kafka-compatible data-streaming platform.  Confluent Acquires WarpStream

Personalis Announces Expanded Collaboration With Tempus AI

Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its expanded commercial relationship with Tempus AI, including an equity investment by Tempus into Personalis. Personalis and Tempus agreed in November 2023 to collaborate and bring ultra-sensitive minimal residual disease (MRD) testing to market and […]

Transact Campus Announces $1.6 Billion Sale to Roper Technologies

Cooley advised Transact Campus, an innovative campus technology and payment solutions company (and portfolio company of Reverence Capital Partners), on a definitive agreement signed by Reverence Capital Partners to sell Transact to Roper Technologies for $1.6 billion.  Transact Campus Announces $1.6 Billion Sale to Roper Technologies

Cents Announces $40 Million Series B Financing and Acquisition of Laundroworks

Cooley advised Cents, the top all-in-one business management platform powering garment care small- and medium-sized businesses (SMBs), on its $40 million Series B financing, as well as its acquisition of Laundroworks, a hardware-based payments system powering how consumers pay for laundry at laundromats and shared laundry rooms within multifamily buildings, hotels, […]

PetIQ Announces Definitive Merger Agreement With Bansk Group Valued at Approximately $1.5 Billion

Cooley advised PetIQ (Nasdaq: PETQ), a top pet medication, health and wellness company, on its definitive merger agreement with Bansk Group, pursuant to which Bansk Group will acquire all outstanding shares of PetIQ’s common stock for $31 per share in an all-cash transaction valued at approximately $1.5 billion. PetIQ Announces Definitive […]

Boldend to Sell to SIXGEN

Cooley advised Boldend, a top cyber automation company developing software solutions that enhance and scale cyber capabilities, on its acquisition by SIXGEN, a full-spectrum provider of cyber products, operations and solutions to the US national security and critical infrastructure sectors. Boldend to Sell to SIXGEN

BlackSignal Technologies Announces $200 Million Sale to Parsons

Cooley advised BlackSignal Technologies, a digital signal processing and electronic warfare company delivering advanced processing capabilities in support of national security, on its definitive agreement to be acquired by Parsons Corporation in an accretive deal valued at $200 million.  BlackSignal Technologies Announces $200 Million Sale to Parsons

Nerio Therapeutics Sells to Boehringer Ingelheim for up to $1.3 Billion

Cooley advised Nerio Therapeutics, a drug discovery and development company focused on phosphatases, a notoriously difficult class of potentially high-value therapeutic protein targets, on its sale to Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, for up to $1.3 billion.  Nerio Therapeutics Sells to Boehringer Ingelheim for […]

Cepton Signs Definitive Agreement to Sell to Koito

Cooley advised the special committee of the board of directors of Cepton, a Silicon Valley innovator and leader in high-performance light detection and ranging (lidar) solutions, on Cepton’s definitive agreement to be acquired by Koito, a top automotive tier-one supplier.  Cepton Signs Definitive Agreement to Sell to Koito